| [1] Abuchowski A, Van Es T, Palczuk N C, et al. Alteration of immunological properties of bovine serum albumin by covalent attachment of polyethylene glycol.J Biol Chem, 1977, 252(11):3578-3581.
[2] 王旭东,李晓晖,苏志国,等.蛋白药物的聚乙二醇定点修饰策略与最佳位点.中国生物工程杂志, 2010, 30(4):101-109. Wang X D, Li X H, Su Z G, et al. Site-specific PEGylation strategies and suitable modified sites of protein drugs. China Biotechnology, 2010, 30(4):101-109.
[3] World Health Organization. WHO Guidelines on the Quality, Safety, and Efficacy of Biological Medicinal Products Prepared by Recombinant DNA Technology. Switzerland:WHO Press,2013.91-92.
[4] 梁凌宇,王婉茹,郭玉婷,等. RP-HPLC法检测CN10蛋白的PEG化修饰率及含量.微生物学免疫学进展, 2015, 43(1):14-18. Liang L Y, Wang W R, Guo Y T, et al. Determination of modification rate and content of PEGylated CN10 by RP-HPLC. Progress in Microbiology and Immunology, 2015, 43(1):14-18.
[5] 李晶,王永利,杨化新,等.三硝基苯磺酸法测定聚乙二醇化重组人生长激素的平均修饰度.现代生物医学进展, 2011,11(9):1609-1612. Li J, Wang Y L, Yang H X, et al. Determination of average degree of modification of pegylated recombinant human growth hormone by trinitrobenzene sulfonic acid. Progress in Modern Biomedicine, 2011,11(9):1609-1612.
[6] Bullock J, Chowdhury S, Severdia A, et al. Comparison of results of various methods used to determine the extent of modification of methoxy polyethylene glycol 5000-modified bovine cupri-zinc superoxidedismutase. Anal Biochem, 1997, 254(2):254-262.
[7] Stocks S J, Jones A J, Ramey C W, et al. A fluorometric assay of the degree of modification of protein primary amines with polyethylene glycol. Anal Biochem, 1986,154(1):232-234.
[8] 李晶,何辉,程速远,等.荧光胺衍生化法测定3种聚乙二醇化重组人生长激素的平均修饰率.药物分析杂志,2014,34(8):1368-1373. Li J, He H, Cheng S Y, et al. A fluorometric assay to determine the average modification rate of three kinds of PEG-rhGHs. Chin J Pharm Anal, 2014,34(8):1368-1373.
[9] 李晶,梁成罡.聚乙二醇化重组人生长激素质控难点探讨.中国新药杂志,2014,23(3):271-274. Li J, Liang C G. Difficulties in quality control of PEGylated rhGH. Chinese Journal of New Drugs,2014,23(3):271-274.
[10] 李修乐.聚乙二醇化蛋白的修饰位点识别研究.泰安:山东农业大学食品科学与工程学院, 2013. Li X L. Methods for identification of conjugationsite on pegylated protein. Taian:Institute of Food Science and Engineering, Shandong Agricultural University, 2013.
[11] Monkarsh S P, Ma Y, AglioneA,et al. Positional isomers of monopegylated interferon alpha-2a:isolation, characterization, and biological activity.Anal Biochem, 1997,247(2):434-440.
[12] Yu W L, Yu C M, Wu L, et al. PEGylated recombinant human interferon-x as a long-acting antiviral agent:Structure, antiviral activity and pharmacokinetics. Antiviral Research, 2014(108):142-147.
[13] Lu X J, Gough P C, DeFelippis M R, et al. Elucidation of PEGylation site with a combined approach of In-source fragmentation and CID MS/MS. J Am Soc Mass Spectrom, 2010, 21(5):810-818.
[14] Yoo C, Suckau D, Sauerland V, et al. Toward top-down determination of PEGylation site using MALDI in-source decay MS analysis. J Am Soc Mass Spectrom,2009,20(2):326-333.
[15] 张苏,张培彪.聚乙二醇化重组人干扰素β-1a注射液中游离聚乙二醇残留量的测定.中国现代应用药学,2014,31(8):966-968. Zhang S, Zhang P B. Determination of Free PEG in PEG-rhIFN-β-1a injection. Chin J Mod Appl Pharm, 2014,31(8):966-968.
[16] 李永红,李响,韩春梅,等.高效液相色谱蒸发光散射检测法测定聚乙二醇干扰素α-2a注射液中游离聚乙二醇的含量.药物生物技术, 2014,21(4):353-354. Li Y H, Li X, Han C M, et al. Quantitation of free polyethylene glycol in PEGylated interferon alpha-2a injection by HPLC-ELSD. Pharmaceutical Biotechnology, 2014,21(4):353-354.
[17] 苑方圆,李晶,梁成罡,等.聚乙二醇(PEG)化尿酸氧化酶中游离PEG的含量测定.药物分析杂志,2014,34(3):461-464. Yuan F Y, Li J, Liang C G, et al. Determination of the content of free polyethylene glycol in PEGylated uricase. Chin J Pharm Anal, 2014,34(3):461-464.
[18] Kurfürst M M. Detection and molecular weight determination of polyethylene glycol-modified hirudin by staining after sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Anal Biochem, 1992, 200(2):244.
[19] Hardy E, Ramón J, Saez V, et al. Detection of PEGylated proteins in polyacrylamide gels by reverse staining withzinc and imidazole salts. Electrophoresis, 2008, 29(11):2363-2371.
[20] Fee C J, Van J M. Prediction of the viscosity radius and the size exclusion chromatography behavior of PEGylatedproteins. Bioconjug Chem, 2004,15(6):1304-1313.
[21] 王军志.生物技术药物研究开发与质量控制.第2版.北京:科学出版社, 2007.71-102. Wang J Z. The Research Development and Quality Control of Biomedical. 2nd ed. Beijing:Science Press, 2007.71-102.
[22] Zheng C Y, Ma G H, Su Z G. Native PAGE eliminates the problem of PEG-SDS interaction in SDS-PAGE and provides an alternative to HPLC in characterization of protein PEGylation. Electrophoresis, 2007, 28(16):2801-2807.
[23] Möller I, Thomas A, Geyer H, et al. Synthesis, characterisation, and mass spectrometric detection of a pegylated EPO-mimetic peptide for sports drug testing purposes. Rapid Communications in Mass Spectrometry, 2011,25(15):2115-2123.
[24] 吴影新,翟艳琴,雷建都,等.聚乙二醇修饰蛋白体系的SDS-聚丙烯酰胺凝胶电泳染色方法新探.化学通报,2005,72(5):459-462. Wu Y X, Zhai Y Q, Lei J D, et al. Application of three kinds of staining methods for PEGylated protein system in SDS-PAGE. Chemistry, 2005,72(5):459-462.
[25] 谭和平,王彧婕,邹燕,等.蛋白质分子质量测试方法概述.中国测试,2011, 37(2):34-37. Tan H P, Wang Y J, Zou Y, et al. Methods of molecular weight determination of proteins. China Measurement & Test, 2011,37(2):34-37.
[26] Huang L, Gough P C, Defelippis M R. Characterization of poly(ethylene glycol)and PEGylated products by LC/MS with postcolumn addition of amines. Anal Chem, 2009, 81(2):567-577.
[27] Foser S, Schacher A, Weyer K A, et al. Isolation, structural characterization, and antiviral activity of positional isomers of monopegylated interferon α-2a(PEGASYS). Protein Expression and Purification, 2003,30(1):78-87.
[28] Huang Y S, Wen X F, Wu Y L, et al. Engineering a pharmacologically superior form of granulocytecolony-stimulating factor by fusion with gelatin-like-protein polymer. Eur J Pharm Biopharm, 2010, 74(3):435-441.
[29] Wadhwa M, Bird C, Dougall T, et al. Establishment of the first international standard for PEGylated granulocyte colony stimulating factor (PEG-G-CSF):report of an international collaborative study. Journal of Immunological Methods, 2015,416:17-28. |
